The Ability of Radiomics from PET/CT in Predicting the Status of PD-L1 Expression and KRAS Mutation in Non-Small Cell Lung Cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2023
- Keyword
-
Krebs
Lungenkrebs
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2023
- Creator
- Contributor
-
Hartmann, Arndt
Hartmann, Arndt
Müller, Fabian
- URN
-
urn:nbn:de:bvb:29-opus4-239316
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:55 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Ruiyun
- Hartmann, Arndt
- Müller, Fabian
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2023
Other Objects (12)
Frequency and clinicopathologic correlates of KRAS amplification in Non-small cell lung carcinoma
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR
AutoRadiomics: a framework for reproducible radiomics research
"KRAS
Kras
PET/CT radiomics and machine learning for non-invasive molecular and prognostic characterization of oropharyngeal squamous cell carcinomas
Neuartige Strategien zur Behandlung von onkogenem KRAS und dessen Einfluss auf das Immuncheckpointmolekül PD-L1 in soliden Tumoren
DV-47/19.- Ersatzteilkatalog für die Kraftfahrzeuge KRAS-214, KRAS-219, KRAS-221 und KRAS-222
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
KRaS
Kras - Lien
Frequency and clinicopathologic correlates of KRAS amplification in Non-small cell lung carcinoma
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR
AutoRadiomics: a framework for reproducible radiomics research
"KRAS
Kras
PET/CT radiomics and machine learning for non-invasive molecular and prognostic characterization of oropharyngeal squamous cell carcinomas
Neuartige Strategien zur Behandlung von onkogenem KRAS und dessen Einfluss auf das Immuncheckpointmolekül PD-L1 in soliden Tumoren
DV-47/19.- Ersatzteilkatalog für die Kraftfahrzeuge KRAS-214, KRAS-219, KRAS-221 und KRAS-222
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
KRaS
Kras - Lien
Frequency and clinicopathologic correlates of KRAS amplification in Non-small cell lung carcinoma
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR
AutoRadiomics: a framework for reproducible radiomics research
"KRAS
Kras
PET/CT radiomics and machine learning for non-invasive molecular and prognostic characterization of oropharyngeal squamous cell carcinomas
Neuartige Strategien zur Behandlung von onkogenem KRAS und dessen Einfluss auf das Immuncheckpointmolekül PD-L1 in soliden Tumoren
DV-47/19.- Ersatzteilkatalog für die Kraftfahrzeuge KRAS-214, KRAS-219, KRAS-221 und KRAS-222
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
KRaS